Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-FR Version v4-FR
Language French French
Date Updated 2024-06-03 2024-04-10
Drug Identification Number 02260565 02260565
Brand name XOLAIR XOLAIR
Common or Proper name XOLAIR 150MG/5ML VIALS 1 X1 XOLAIR 150MG/5ML VIALS 1 X1
Company Name NOVARTIS PHARMACEUTICALS CANADA INC NOVARTIS PHARMACEUTICALS CANADA INC
Ingredients OMALIZUMAB OMALIZUMAB
Strength(s) 150MG 150MG
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration SUBCUTANEOUS SUBCUTANEOUS SUBCUTANEOUS SUBCUTANEOUS
Packaging size 1 X 5ML 1 X 5ML
ATC code R03DX R03DX
ATC description OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2024-08-31 2024-08-31
Actual start date
Estimated end date 2024-09-30 2024-09-30
Actual end date 2024-06-03
Shortage status Avoided shortage Anticipated shortage
Tier 3 Status No No
Company comments Limited quantities available Limited quantities available
Health Canada comments